Skip to main content
Equibles
AMGN logo

AMGN · Amgen Inc · Metrics

Track AMGN — free

Use AMGN with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research AMGN.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$439.26 -8.02 (-1.79%) At close · Oct 23
S&P 500 member Nasdaq-100 member Russell 1000 member Dow 30 member Rebalance outlook locked
Market Cap
$237.48B
Shares
540.63M
Volume · Oct 23 2.08M Avg daily vol (3M) 2.82M

AMGN metrics

118 of 122 screener metrics currently available.

Open in screener

Market overview

2 metrics
Share price
$439.26
Market cap
$237.48B

Price action

20 metrics
Price change (1W)
+1.6%
Price change (30D)
+5.9%
Price change (3M)
+16.8%
Price change (6M)
+27.5%
Price change (YTD)
+34.2%
Price change (1Y)
+50.0%
Trailing year
Price change (5Y)
+109.9%
52-week high
$447.28
52-week low
$291.16
Change from 52-week high
-1.8%
Change from 52-week low
+50.9%
Annualized volatility
29.6%
Annualized volatility (3M)
34.4%
Beta
0.5
RSI (14D)
60.8
Price vs SMA 50
+5.3%
Price vs SMA 200
+18.2%
Avg volume (3M)
2.82M
Relative volume
0.7
Average dollar volume
$1.15B

Company

3 metrics
Sector
Healthcare
Industry
Drug Manufacturers - General
Shares outstanding
540.63M

Valuation

12 metrics
P / E (TTM)
27.3
Trailing earnings · reciprocal yield 3.7%
PEG ratio
0.4
EV / revenue
7.4×
reciprocal yield 13.6%
EV / EBITDA
17.2×
reciprocal yield 5.8%
EV / EBIT
24.6×
reciprocal yield 4.1%
P / sales
6.2×
reciprocal yield 16.0%
P / book
20.3
reciprocal yield 4.9%
FCF yield
4.3%
TTM · current market cap
Buyback yield
0.0%
P / FCF
23.3
reciprocal yield 4.3%
P / operating cash flow
19.0
reciprocal yield 5.3%
Earnings yield
3.7%

Historical valuation

8 metrics
P / E historical average (3Y)
30.6×
reciprocal yield 3.3%
P / E historical average (5Y)
26.5×
reciprocal yield 3.8%
EV / revenue historical average (3Y)
6.5×
reciprocal yield 15.3%
EV / revenue historical average (5Y)
6.3×
reciprocal yield 15.8%
EV / EBIT historical average (3Y)
27.0×
reciprocal yield 3.7%
EV / EBIT historical average (5Y)
23.5×
reciprocal yield 4.3%
EV / EBITDA historical average (3Y)
18.9×
reciprocal yield 5.3%
EV / EBITDA historical average (5Y)
16.7×
reciprocal yield 6.0%

Dividends & buybacks

7 metrics
Dividend yield
2.3%
Trailing 12 months
Payout ratio
60.4%
Shareholder yield
—
Dividend / share (TTM)
$9.94
Dividend growth YoY
+5.9%
Dividend growth streak
5+
Stored dividend history starts 2020
Last ex-dividend
2026-08-21

Earnings calendar

2 metrics
Next earnings
—
Last earnings
2026-04-08

Profitability

9 metrics
Gross margin
69.5%
Operating margin
30.0%
Trailing 12 months
Net margin
23.0%
Gross profit (TTM)
$26.48B
Operating profit (TTM)
$11.43B
Net income (TTM)
$8.74B
Trailing 12 months
Diluted EPS (TTM)
$16.09
FCF margin
26.7%
Effective tax rate
15.0%

Per share

11 metrics
Revenue per diluted share (TTM)
$70.09
Gross profit per diluted share (TTM)
$48.72
Operating profit per diluted share (TTM)
$21.02
EBITDA per diluted share (TTM)
$30.03
Net income per diluted share (TTM)
$16.09
Operating cash flow per diluted share (TTM)
$22.97
Free cash flow per diluted share (TTM)
$18.73
Capital expenditures per diluted share (TTM)
$4.24
R&D per diluted share (TTM)
$14.04
Stock compensation per diluted share (TTM)
$0.91
Book value per share
$16.07

Growth

11 metrics
Revenue growth YoY
+9.5%
Year over year
Net income growth YoY
+65.9%
Revenue (TTM)
$38.09B
Trailing 12 months
EPS growth YoY
+64.9%
Shares change YoY
+0.6%
Year over year · more shares
Revenue CAGR (3Y)
+11.8%
Revenue CAGR (5Y)
+7.6%
EPS CAGR (3Y)
+5.5%
EPS CAGR (5Y)
+2.9%
FCF CAGR (3Y)
-2.7%
FCF CAGR (5Y)
-3.9%

Quality

14 metrics
Return on equity
74.8%
Return on assets
9.1%
Debt / equity
4.9
Current ratio
1.4
EBITDA (TTM)
$16.32B
Free cash flow (TTM)
$10.18B
Quick ratio
1.1
Interest coverage
—
Net debt / EBITDA
2.7
Return on invested capital
17.7%
Trailing 12 months
Net cash
−$43.31B
Latest balance sheet
Cash & equivalents
$13.99B
Total assets
$95.64B
Total debt
$57.30B

Cash flow & spend

7 metrics
Operating cash flow (TTM)
$12.48B
Capital expenditures (TTM)
$2.30B
R&D (TTM)
$7.63B
SG&A (TTM)
$7.02B
Stock compensation (TTM)
$492.00M
R&D / revenue
20.0%
Stock compensation / revenue
1.3%

Ownership (13F)

9 metrics
13F filers
3,185
13F filer change QoQ
+18
Institutional ownership
84.5%
Conviction holders (share of 13F filers)
1.8%
Crowding (high-turnover and private-fund holders)
7.5%
Private-fund adviser ownership
7.1%
Active holders' share change QoQ
+2.0%
Holder tenure
18.3
Price vs estimated holder cost
+17.3%

Ownership (registered funds)

1 metrics
Index-fund ownership
20.9%

Short interest

3 metrics
Short interest
2.6%
Latest settlement · 4.1 days to cover
Days to cover
4.1d
Short-squeeze score
61 / 100

Insider activity

2 metrics
Net insider buying (90D)
−$4.11M
Insider-sentiment score
29 / 100

Risk flags

1 metrics
Going concern
—
Key facts CIK 318154 CUSIP 031162100 13F (30d) 1090 filings 1064 filers Visit website Investor relations